A conference focused on advancements in cancer treatment using nanotechnology.
Official title: 2025 Cancer Nanotechnology Gordon Research Conference and Gordon Research Seminar
Funded at Gordon Research Conferences · NIH-11074171 · Data updated 2026-11-12
This conference brings together top scientists and researchers to share new ideas and discoveries about using tiny technology to improve cancer diagnosis and treatment, making it a great opportunity for professionals from different fields to learn and work together.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Gordon Research Conferences NIH-funded |
| Lab location | 1 site (East Greenwich, UNITED STATES) |
| Project start | February 1, 2025 |
| Project end | January 31, 2026 |
| Funding year | 2025 |
| Award (this year) | $5,000 |
| NIH project number | 1R13CA298639-01 |
| Project ID | NIH-11074171 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for benefiting from this research are patients with advanced cancer who may benefit from cutting-edge nanotechnology therapies.
✕Less likely to help
Patients who are not currently engaged in cancer treatment or those with early-stage cancer may not receive direct benefits from this conference.
What this research studies
The Cancer Nanotechnology Gordon Research Conference (CN-GRC) aims to gather leading experts and emerging scientists to share innovative findings in cancer research, particularly through the use of nanotechnology. This conference will facilitate discussions on the latest breakthroughs in cancer diagnosis and treatment, while also promoting the translation of nanomedicine technologies into practical applications. Attendees will include a diverse group of professionals from various fields, including chemistry, biology, and clinical research, fostering collaboration and education among participants.
Why it matters
Potential benefit: If successful, this conference could lead to significant advancements in cancer treatment and diagnosis, ultimately improving patient outcomes.
How similar studies have gone: Previous conferences and research initiatives in cancer nanotechnology have shown promising advancements, indicating a strong potential for success in this area.
Where this research is happening
-
Gordon Research Conferences
East Greenwich, United States Active
Researchers
- Principal investigator: Heller, Daniel Alan — Gordon Research Conferences
- Study coordinator: Heller, Daniel Alan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.